comparemela.com

Latest Breaking News On - Yafit lazar - Page 1 : comparemela.com

EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt In China

EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt In China TEL-AVIV, Israel, April 7, 2021 /PRNewswire/ EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt was granted the Innovative Device Status by China s Center for Medical Device Evaluation, the arm of the National Medical Products Administration (NMPA). Following the announcement, the EndoArt became the only ophthalmic device in the world to receive both China s Innovative Device Status and the Breakthrough Device Designation from the U.S. Food and Drug Administration. The EndoArt is the world s first synthetic implant that enables doctors to treat chronic corneal edema, the main reason for the world s most common organ transplant, with a minimally invasive surgery that erodes the use of human tissue.The EndoArt is designed to replace dysfunctional endothelium in patients awaiting human donor t

China
India
Israel
Israeli
Richel-liu
Nahum-ferera
Kostenloser-wertpapierhandel
Yafit-lazar
China-national-medical-products-administration
National-medical-products-administration
Drug-administration
China-center

EyeYon Medical Raises $25 million in Series C to Transform Corneal Care

EyeYon Medical Raises $25 million in Series C to Transform Corneal Care USA - English News provided by Share this article Share this article TEL AVIV, Israel, March 15, 2021 /PRNewswire/ EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund. Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. EyeYon Medical was founded in 2011 by Dr. Ofer Daphna, CEO Nahum Ferera MD, and Dr. Arie Marcovich, MD., and develops advanced technology to treat acute problems in the ophthalmic world. The latest round brings the total amount of capital raised by the company to $36 million.

China
United-states
Israel
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Amsterdam
Noord-holland
Netherlands
Nahum-ferera
Richel-liu
Yafit-lazar

WHEN Group Announces Appointment of Maj. Gen. (Ret.) Danny Yatom, Former Director of Mossad, as Company President – Business

WHEN Group Announces Appointment of Maj. Gen. (Ret.) Danny Yatom, Former Director of Mossad, as Company President – Business
ipsnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipsnews.net Daily Mail and Mail on Sunday newspapers.

Jerusalem
Israel-general
Israel
Hebrew-university
Yerushalayim
Israeli
Boca-raton
Shimon-peres
Danny-yatom
Yitzhak-rabin
Ehud-barak
Yafit-lazar

WHEN Group Announces Appointment of Maj. Gen. (Ret.) Danny Yatom, Former Director of Mossad, as Company President

WHEN Group Announces Appointment of Maj. Gen. (Ret.) Danny Yatom, Former Director of Mossad, as Company President
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

Jerusalem
Israel-general
Israel
Hebrew-university
Yerushalayim
Israeli
Boca-raton
Shimon-peres
Danny-yatom
Yitzhak-rabin
Ehud-barak
Yafit-lazar
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.